Nebraska to Get Nearly $5M in Depakote Settlements

By: Associated Press
By: Associated Press

Nebraska will receive nearly $5 million from Abbott Laboratories to settle concerns that it improperly marketed its anti-seizure drug Depakote.

Nebraska Attorney General Jon Bruning says the state will receive a share of the $1.5 billion settlement Abbott agreed to.

Nebraska's Medicaid program will receive $3.7 million, and $1.2 million will go to the state's consumer settlement fund.

Depakote is an anti-seizure and mood-stabilizing drug that's prescribed for bipolar disorder. Abbott admitted marketing Depakote for unapproved uses including dementia and schizophrenia in violation of FDA rules.

The national settlement was announced Monday.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLN-TV Call: (402) 467-4321 Toll-free: 1-800-475-1011 840 North 40th Lincoln, NE 68503 Email: KGIN-TV Call: (308) 382-6100 123 N Locust Street Grand Island, NE 68802 Email: KSNB-TV Toll free 888-475-1011 123 N. Locust St. Grand Island, NE 68802 Email :
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 150597265 -
Gray Television, Inc.